|
38 Companies |
|
50 Products |
|
50 Products |
|
51 Mechanisms of Action |
|
3 Trials |
|
1814 News |
|
| «12...20212223242526272829303132» |
- Trial initiation date: Impact of a Gene Test for Susceptibility to Lung Cancer in Smokers (clinicaltrials.gov) - Jan 5, 2012
P=N/A, N=80, Recruiting, Sponsor: University of Surrey
Initiation date: Oct 2010 --> Sep 2011
- Enrollment open: Impact of a Gene Test for Susceptibility to Lung Cancer in Smokers (clinicaltrials.gov) - Jan 5, 2012
P=N/A, N=80, Recruiting, Sponsor: University of Surrey
Initiation date: Oct 2010 --> Sep 2011 Not yet recruiting --> Recruiting
- Trial withdrawal: Nicotinic Receptor Density in Smoking and Nonsmoking Schizophrenics (clinicaltrials.gov) - Dec 29, 2011
P=N/A, N=0, Withdrawn, Sponsor: National Institute on Drug Abuse (NIDA)
Not yet recruiting --> Recruiting Completed --> Withdrawn
- Enrollment change: Nicotinic Receptor Density in Smoking and Nonsmoking Schizophrenics (clinicaltrials.gov) - Dec 29, 2011
P=N/A, N=0, Withdrawn, Sponsor: National Institute on Drug Abuse (NIDA)
Completed --> Withdrawn N=30 --> 0
- Enrollment closed: 'Questions About Quitting' Smoking Cessation Trial (clinicaltrials.gov) - Dec 22, 2011
P=N/A, N=1865, Active, not recruiting, Sponsor: Group Health Cooperative
N=30 --> 0 Recruiting --> Active, not recruiting
- ||| Chantix (varenicline) / Pfizer
Enrollment closed: An Alternative Dosing Schedule of Varenicline for Smoking Cessation (clinicaltrials.gov) - Dec 21, 2011
P2, N=60, Active, not recruiting, Sponsor: Roswell Park Cancer Institute
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- | Trial completion: Mindfulness and Cancer Mamma - Clinical Trial MBSR Among Women Operated for Breast Cancer (clinicaltrials.gov) - Dec 21, 2011
P2/3, N=336, Completed, Sponsor: Danish Cancer Society
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- |||| Chantix (varenicline) / Pfizer
Enrollment open: EAGLES: Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders (clinicaltrials.gov) - Dec 20, 2011
P4, N=8000, Recruiting, Sponsor: Pfizer
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- | New P1/2 trial: SSTOP: Smoking Cessation Intervention for Diabetic Patients (clinicaltrials.gov) - Dec 20, 2011
P1/2, N=72, Recruiting, Sponsor: Rhode Island Hospital
- ||| Trial completion: Smoking Research Study (clinicaltrials.gov) - Dec 19, 2011
P=N/A, N=88, Completed, Sponsor: Philip Morris Products S.A.
Not yet recruiting --> Recruiting Recruiting --> Completed
- Trial completion: A Novel Treatment to Boost Quit Attempts and Cessation Among Unmotivated Smokers (clinicaltrials.gov) - Dec 7, 2011
P=N/A, N=849, Completed, Sponsor: Medical University of South Carolina
Recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: Group Counseling for Smoking Cessation (clinicaltrials.gov) - Dec 6, 2011
P1/2, N=240, Completed, Sponsor: American University
Active, not recruiting --> Completed No longer recruiting --> Completed
- ||| Trial completion: Study to Evaluate the Safety and Efficacy of Dietary Supplement Anatabloc in Reducing Daily Smokers' Urge to Smoke (clinicaltrials.gov) - Dec 4, 2011
P1, N=109, Completed, Sponsor: Rock Creek Pharmaceuticals, Inc.
No longer recruiting --> Completed Active, not recruiting --> Completed
- New P1 trial: DDAT: SPECT Imaging of DAT Genotype (clinicaltrials.gov) - Dec 1, 2011
P1, N=40, Recruiting, Sponsor: University of Pennsylvania
- ||| methylphenidate prolonged release tablet - 12 hrs acting / Generic mfg.
Enrollment change: Prevention of Cigarette Smoking in Attention Deficit Hyperactivity Disorder (ADHD) Youth With Concerta (clinicaltrials.gov) - Nov 30, 2011
P4, N=203, Completed, Sponsor: Massachusetts General Hospital
Active, not recruiting --> Completed N=164 --> 203
- ||||| New P2 trial: Substance Treatment and HIV Testing and Referral System (clinicaltrials.gov) - Nov 30, 2011
P2, N=140, Not yet recruiting, Sponsor: Polaris Health Directions
- | New P2 trial: Interactive Voice Response Technology to Mobilize Contingency Management for Smoking Cessation (clinicaltrials.gov) - Nov 30, 2011
P2, N=90, Recruiting, Sponsor: University of Connecticut Health Center
- Enrollment open: Emergency Department Smoking Cessation Study (clinicaltrials.gov) - Nov 30, 2011
P=N/A, N=924, Recruiting, Sponsor: University of British Columbia
N=164 --> 203 Not yet recruiting --> Recruiting
- Enrollment closed: Impact of Smoking Cessation and γ-Tocopherol to Restore Vascular Endothelial Function (clinicaltrials.gov) - Nov 29, 2011
P1/2, N=67, Active, not recruiting, Sponsor: University of Connecticut
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- bupropion / Generic mfg.
Trial completion: Smoking Cessation Medications: Efficacy, Mechanisms and Algorithms (clinicaltrials.gov) - Nov 28, 2011
P4, N=1504, Completed, Sponsor: University of Wisconsin, Madison
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- bupropion / Generic mfg.
Trial completion: Smoking Cessation Intervention: Effectiveness in Primary Care (clinicaltrials.gov) - Nov 28, 2011
P4, N=1346, Completed, Sponsor: University of Wisconsin, Madison
Active, not recruiting --> Completed Active, not recruiting --> Completed
- || Chantix (varenicline) / Pfizer
Enrollment change: Varenicline Effects on Cue Reactivity and Smoking Reward/Reinforcement (clinicaltrials.gov) - Nov 27, 2011
P=N/A, N=163, Completed, Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Active, not recruiting --> Completed N=106 --> 163
- ||| Chantix (varenicline) / Pfizer
Trial completion: Varenicline Effects on Cue Reactivity and Smoking Reward/Reinforcement (clinicaltrials.gov) - Nov 27, 2011
P=N/A, N=163, Completed, Sponsor: H. Lee Moffitt Cancer Center and Research Institute
N=106 --> 163 Active, not recruiting --> Completed
- | encenicline (EVP-6124) / Forum Pharmaceuticals, Mitsubishi Tanabe
New P2 trial: A Safety and Cognitive Function Study of EVP-6124 Versus Placebo in Subjects With Nicotine Dependence (clinicaltrials.gov) - Nov 24, 2011
P2, N=450, Recruiting, Sponsor: A. Eden Evins
- Trial completion: Effect of Stress-management and Biofeedback on Craving in Smoking Abstinence: A Pilot Study (clinicaltrials.gov) - Nov 24, 2011
P2, N=40, Completed, Sponsor: University Hospital, Ghent
Active, not recruiting --> Completed Not yet recruiting --> Completed
- || Chantix (varenicline) / Pfizer
Enrollment change: Smoke-Free Living Study (clinicaltrials.gov) - Nov 22, 2011
P1, N=100, Completed, Sponsor: University of British Columbia
Not yet recruiting --> Completed N=81 --> 100
- ||| Chantix (varenicline) / Pfizer
Trial completion: Smoke-Free Living Study (clinicaltrials.gov) - Nov 22, 2011
P1, N=100, Completed, Sponsor: University of British Columbia
N=81 --> 100 Recruiting --> Completed
- ||| New P1 trial: Safety and Pharmacodynamics of SEL-068 Vaccine in Smokers and Non-Smokers (clinicaltrials.gov) - Nov 21, 2011
P1, N=80, Active, not recruiting, Sponsor: Selecta Biosciences, Inc.
- ||| Hetlioz (tasimelteon) / Vanda
New P1 trial: Effects of Smoking, Age and Body Size on Pharmacokinetics, Safety and Tolerability on Tasimelteon in Healthy Subjects (clinicaltrials.gov) - Nov 20, 2011
P1, N=60, Completed, Sponsor: Vanda Pharmaceuticals
- | Chantix (varenicline) / Pfizer
New P4 trial: Sympathovagal Balance in Smoking Cessation (clinicaltrials.gov) - Nov 16, 2011
P4, N=85, Active, not recruiting, Sponsor: Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH
- | New P4 trial: Emerging Adults Who Use Alcohol and Marijuana (clinicaltrials.gov) - Nov 15, 2011
P4, N=500, Recruiting, Sponsor: Butler Hospital
- |||| aspirin / Generic mfg., clopidogrel / Generic mfg., prasugrel / Generic mfg.
Trial completion: The Influence of Smoking Status on Prasugrel and Clopidogrel Treated Subjects Taking Aspirin and Having Stable Coronary Artery Disease (clinicaltrials.gov) - Nov 8, 2011
P4, N=110, Completed, Sponsor: Daiichi Sankyo Inc.
Recruiting --> Completed Recruiting --> Completed
- |||| Chantix (varenicline) / Pfizer
Enrollment open: Varenicline In-Patient Study (clinicaltrials.gov) - Nov 7, 2011
P2, N=80, Recruiting, Sponsor: Stanford University
Recruiting --> Completed Not yet recruiting --> Recruiting
- budesonide / Generic mfg.
Trial completion: Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung Cancer (clinicaltrials.gov) - Nov 3, 2011
P2, N=225, Completed, Sponsor: M.D. Anderson Cancer Center
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- Trial completion: The Effectiveness of Smoking Cessation Guidelines in the Emergency Department (clinicaltrials.gov) - Nov 2, 2011
P=N/A, N=789, Completed, Sponsor: University of Iowa
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Enrollment change: Tobacco Cessation Via Doctors of Chiropractic (clinicaltrials.gov) - Oct 24, 2011
P=N/A, N=201, Completed, Sponsor: Oregon Research Institute
Active, not recruiting --> Completed N=1530 --> 201
- Trial completion: Tobacco Quitlines:Adjunct to Dental Office Tobacco Intervention (clinicaltrials.gov) - Oct 24, 2011
P2, N=2177, Completed, Sponsor: Oregon Research Institute
N=1530 --> 201 Recruiting --> Completed
- Trial completion: PHD2: Tobacco Cessation Via Public Health Dental Clinics (clinicaltrials.gov) - Oct 20, 2011
P2, N=2637, Completed, Sponsor: Oregon Research Institute
Recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: Tobacco Cessation Via Doctors of Chiropractic (clinicaltrials.gov) - Oct 20, 2011
P=N/A, N=201, Completed, Sponsor: Oregon Research Institute
Active, not recruiting --> Completed Recruiting --> Completed
- New P1 trial, Metastases: Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung Cancer (clinicaltrials.gov) - Oct 20, 2011
P1, N=10, Active, not recruiting, Sponsor: Comprehensive Cancer Center of Wake Forest University
- Trial completion: Physiological, Cognitive and Cerebral Activity Changes as a Function of Cigarette Smoking (With or Without Nicotine) and Tobacco Abstinence (clinicaltrials.gov) - Oct 20, 2011
P=N/A, N=125, Completed, Sponsor: National Institute on Drug Abuse (NIDA)
Recruiting --> Completed Recruiting --> Completed
- ||||| Chantix (varenicline) / Pfizer
New P4 trial: EAGLES: Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders (clinicaltrials.gov) - Oct 19, 2011
P4, N=8000, Recruiting, Sponsor: Pfizer
- Enrollment closed: Supplemental Nicotine Administration for Smoking Cessation in Posttraumatic Stress Disorder (PTSD) (clinicaltrials.gov) - Oct 18, 2011
P=N/A, N=81, Active, not recruiting, Sponsor: Duke University
Recruiting --> Completed Recruiting --> Active, not recruiting
- | Chantix (varenicline) / Pfizer
Trial completion: Combination of Nicotine Replacement Therapy (NRT) and Varenicline to Increase Cessation of Tobacco (CONVICT Study) (clinicaltrials.gov) - Oct 17, 2011
P3, N=117, Completed, Sponsor: Queen Mary University of London
Recruiting --> Active, not recruiting Recruiting --> Completed
- New P1 trial: Cell Phone-Based Expert Systems for Smoking Cessation (clinicaltrials.gov) - Oct 17, 2011
P1, N=446, Completed, Sponsor: VA Pacific Islands Health Care System
- | New P2 trial: Development of Positive Psychotherapy for Smoking Cessation (clinicaltrials.gov) - Oct 12, 2011
P2, N=80, Active, not recruiting, Sponsor: Brown University
- Enrollment open: Community-Partnered Dominican Republic Tobacco Control (clinicaltrials.gov) - Oct 12, 2011
P=N/A, N=3656, Recruiting, Sponsor: University of Rochester
Recruiting --> Completed Not yet recruiting --> Recruiting
- Trial completion: Intranet-based Tobacco Prevention Program for Children (clinicaltrials.gov) - Oct 12, 2011
P=N/A, N=3225, Completed, Sponsor: Oregon Research Institute
Not yet recruiting --> Recruiting Enrolling by invitation --> Completed
- selegiline / Generic mfg.
Trial termination: Testing a Full Substitution Therapy Approach As Treatment of Tobacco Dependence (clinicaltrials.gov) - Oct 6, 2011
P=N/A, N=40, Terminated, Sponsor: Centre for Addiction and Mental Health
Enrolling by invitation --> Completed Active, not recruiting --> Terminated; Preliminary results did not support the utility of combining selegeline + NRT.
- Trial completion: Yoga for Smoking Cessation Feasibility Study (clinicaltrials.gov) - Oct 5, 2011
P=N/A, N=30, Completed, Sponsor: The Miriam Hospital
Active, not recruiting --> Terminated; Preliminary results did not support the utility of combining selegeline + NRT. Active, not recruiting --> Completed